Nephros (NEPH) Stock Chart & Stock Price History $1.60 +0.05 (+2.90%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Nephros Stock Price Performance 5 Day Performance+7.11%1 Month Performance+2.97%3 Month Performance+7.11%6 Month Performance-8.80%Year-To-Date Performance+8.57%1 Year Performance-32.66% Receive NEPH Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Nephros and its competitors with MarketBeat's FREE daily newsletter. Email Address NEPH Stock Chart for Monday, March, 24, 2025 NEPH Chart by TradingViewRemove Ads Nephros Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/21/2025$1.50$1.55+3.33%$1.55$1.4914,062 shs$16.34 million03/20/2025$1.49$1.50+0.67%$1.55$1.494,675 shs$15.82 million03/19/2025$1.52$1.49-1.97%$1.51$1.4914,490 shs$15.71 million03/18/2025$1.59$1.52-4.40%$1.60$1.526,121 shs$16.03 million03/17/2025$1.59$1.59$1.74$1.507,911 shs$16.77 million03/14/2025$1.62$1.59-1.85%$1.75$1.538,812 shs$16.77 million03/13/2025$1.66$1.62-2.41%$1.62$1.58983 shs$17.08 million03/12/2025$1.62$1.66+2.47%$1.76$1.572,849 shs$17.50 million03/11/2025$1.63$1.62-0.31%$1.81$1.5223,380 shs$17.08 million03/10/2025$1.65$1.63-1.52%$1.84$1.6029,159 shs$17.13 million Get the Latest News and Ratings for NEPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Nephros and its competitors with MarketBeat's FREE daily newsletter. 03/07/2025$1.43$1.65+15.44%$1.70$1.5111,387 shs$17.40 million03/06/2025$1.46$1.43-2.10%$1.59$1.4310,337 shs$15.07 million03/05/2025$1.48$1.46-1.35%$1.55$1.457,144 shs$15.39 million03/04/2025$1.41$1.48+4.96%$1.48$1.409,047 shs$15.61 million03/03/2025$1.51$1.41-6.62%$1.49$1.3951,421 shs$14.87 million02/28/2025$1.56$1.51-2.96%$1.66$1.513,304 shs$15.92 million02/27/2025$1.53$1.56+1.70%$1.60$1.601,623 shs$16.41 million02/26/2025$1.46$1.53+4.79%$1.53$1.464,270 shs$16.13 million02/25/2025$1.55$1.46-5.81%$1.51$1.4648,326 shs$15.39 million02/24/2025$1.57$1.55-1.21%$1.57$1.495,747 shs$16.34 million Related Companies Vivani Medical Stock Chart Fractyl Health Stock Chart iCAD Stock Chart Cytosorbents Stock Chart Microbot Medical Stock Chart Alpha Pro Tech Stock Chart Inovio Pharmaceuticals Stock Chart electroCore Stock Chart Titan Medical Stock Chart Safe Pro Group Inc. Common Stock Stock Chart Receive NEPH Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Nephros and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NEPH) was last updated on 3/24/2025 by MarketBeat.com Staff From Our PartnersTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredMusk’s real agenda in D.C. Companies connected to Elon’s new map of America are making major climbs in price. And on May 30, the next wav...Porter & Company | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nephros, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nephros With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.